Allianz Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Allianz Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-58,284	Closed	-$10.1M	–	2625
2015 Q1	$10.1M	Sell	58,284 -54,372	-48%	-$7.98M	0.01%	947
2014 Q4	$12.9M	Sell	112,656 -283,397	-72%	-$34.3M	0.01%	855
2014 Q3	$61M	Buy	396,053 +66,282	+20%	+$9.61M	0.07%	319
2014 Q2	$40.7M	Buy	329,771 +69,807	+27%	+$7.72M	0.05%	388
2014 Q1	$26.7M	Buy	259,964 +107,277	+70%	+$11M	0.03%	477
2013 Q4	$13.7M	Buy	152,687 +48,730	+47%	+$3.89M	0.02%	620
2013 Q3	$6.95M	Buy	103,957 +10,473	+11%	+$722K	0.01%	810
2013 Q2	$6.18M	Buy	+93,484	New	+$5.35M	0.01%	811

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

Allianz Asset Management's SLXP Position: Q2 2015 in Review

Allianz Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 58,284 shares — an estimated $10.1M sold.

Allianz Asset Management first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $61M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Allianz Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Allianz Asset Management sold 58,284 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $10.1M.
Allianz Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Allianz Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $61M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Allianz Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.